Predicts Mortality by AST/ALT Ration in Patients with Sepsis and Septic Shock During ICU Admissin

Clinical trial NCT06683794 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06683794
Sponsor: Nermeen Gamil Ahmed
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

E Prognostic Value of the AST/ALT Ratio Vs. APACHE II Score in Patients with Sepsis and Septic Shock

Start date: 2024-11-01
Primary completion: 2025-11-01
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.